The companies in the biopreservation media market are introducing new products, driven by their increasing demand due to their benefits as well as the steps taken by the government to enhance the preservation of body organs. The global market comprises North America, Europe, Asia-Pacific, and Rest of the World, where North America holds the leading market share. The application areas of this market are regenerative medicines, drug discovery, and biobanking. On the basis of type, this market is segmented to home-brew media and pre-formulated media. The home-brew media segment holds the larger share amongst the two owing to low cost of raw materials.
Ask for the Customized Reports Depending on the Requirement of the Business @
http://www.micromarketmonitor.com/contact/7327611629-request_for_customization.html
Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation, and banking. Biopreservation media helps in efficient storage and archival of this data. It is a universally recognized effective method of preservation which ensures on-demand supply of the best quality tissues, organs, and cells. It has proved to be one of the successful methods for the development of anti-aging medicines.
Speak to Analyst@
http://www.micromarketmonitor.com/contact/7327611629-speak_to_analyst.html
Rising investments by pharmaceutical and biotechnology companies across the world in biobanking and research is to identify the cause of diseases as well as to improve diagnostics, public health, and preventive measures which are the key drivers of this market. Several organizations and societies, such as the International Society for Biological and Environmental Repositories (ISBER), Advancing Transfusion and Cellular Therapies Worldwide (AABB), American Association of Blood Banks (AABB), and European, Middle Eastern & African Society for Biopreservation and Biobanking (ESBB) are focussing on cellular therapy, biopreservation, and biobanking since the last couple of decades. These efforts are directed towards creation of advanced methods of preservation, which will be useful for developing medicines and storage of human tissues or cells.
The report includes in-depth profiles of the key market players along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the global biopreservation media market. The key players in the global biopreservation media market are Essential Pharmaceuticals LLC (U.S.), BioLife Solutions, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Lonza Group Ltd. (Switzerland), Mylan N.V. (U.S.), Genzyme Corporation (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Akron Biotech (U.S.), OriGen Biomedical (U.S.), and Wak-Chemie Medical GmbH (Germany).
